Growing life sciences business to improve overall margins and drive growth in future: Currently, life sciences business contributes to around 70% of the company's revenue. In Q3FY16, the growth in the Life Sciences order book has resulted in an increase of 20.7% over the previous year in total order book of US$ 80.5 Mn. Take Solutions recently consolidated all their life sciences operations under a new brand Navitas. This will help them further to focus more on life sciences business. We expect the high margin life sciences business which has an EBITDA margin in the range of 25-30% to continue its healthy growth and drive the firm's top line and bottom line.